相关实验视频

Updated: May 6, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

[当前对局部晚期不可切除的非小细胞肺癌的管理标准]

Corentin Pasquier¹, Jonathan Khalifa²

¹Département de radiothérapie, Institut universitaire du cancer de Toulouse - Oncopole/Institut Claudius-Regaud, 1 avenue Irène-Joliot-Curie, 31000 Toulouse, France.

Bulletin du cancer

|March 28, 2025

概括

对于不可切除的非小细胞肺癌 (NSCLC),同时进行化学放射治疗,然后进行巩固性免疫治疗,可以改善存活率. 本综述详细介绍了当前的2024年治疗方法和本地先进NSCLC的未来策略.

科学领域:

在瘤学瘤学.
肺部病理学肺部病理学
辐射疗法辐射疗法

背景情况:

非小细胞肺癌 (NSCLC) 是最常见的肺癌类型,通常在晚期被诊断出来.
局部先进的NSCLC (LA-NSCLC) 由于患者的可操作性或疾病不可切除性,经常给外科切除带来挑战.
对不可切除的LA-NSCLC的传统治疗包括并发化疗和放射治疗.

研究的目的:

概述2024年不可切除或不可手术的LA-NSCLC目前的标准治疗方法.
探索辐射疗法和全身治疗中新兴的治疗视角,用于这个患者群体.
讨论涉及免疫治疗的新型组合策略.

主要方法:

审查当前的临床指导方针和LA-NSCLC治疗的最新进展.
对化学辐射疗法和巩固性免疫疗法疗效的数据分析.
讨论治疗方式的未来方向.

主要成果:

同时进行化疗放射治疗,然后进行巩固性免疫治疗,显著改善了中位数整体存活率 (OS).
这种综合方法代表了目前对不可切除的LA-NSCLC的护理标准.
目前正在进行的研究重点是优化放射疗法技术和全身疗法,包括免疫疗法组合.

结论:

化学放射治疗后的巩固免疫疗法是不可切割的LA-NSCLC的关键进展.
未来的治疗策略可能需要进一步改进放射治疗和新型免疫疗法组合.
个性化治疗方法对于改善晚期NSCLC的结果至关重要.

关键词:

适应性辐射疗法适应性辐射疗法支气管非小细胞癌 (CBNPC) 是一种化疗化疗是一种化学疗法.化学疗法是一种化学疗法.免疫治疗是一种免疫疗法.免疫疗法是一种免疫疗法.非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.辐射疗法辐射疗法放射疗法 (Radiotherapy) 是一种放射疗法.适应放射治疗的适应性

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...